Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

New FDA breakthrough-drug category--implications for patients.

New FDA breakthrough-drug category--implications for patients. N Engl J Med. 2014 07 03; 371(1):89-90.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.